BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 11169510)

  • 1. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
    Trefzer U; Hofmann M; Reinke S; Guo YJ; Audring H; Spagnoli G; Sterry W
    Melanoma Res; 2006 Apr; 16(2):137-45. PubMed ID: 16567969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
    Lim E; Browning J; MacGregor D; Davis ID; Cebon JS
    Melanoma Res; 2006 Aug; 16(4):347-55. PubMed ID: 16845331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
    de Vries TJ; Trancikova D; Ruiter DJ; van Muijen GN
    Br J Cancer; 1998 Nov; 78(9):1156-61. PubMed ID: 9820172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiosyncrasies of scalp melanoma.
    Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
    Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
    Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
    Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
    Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
    Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of melanoma-associated antigens in melanoma cell cultures.
    Urosevic M; Braun B; Willers J; Burg G; Dummer R
    Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections.
    Kaufmann O; Koch S; Burghardt J; Audring H; Dietel M
    Mod Pathol; 1998 Aug; 11(8):740-6. PubMed ID: 9720502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
    Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
    J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
    Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
    Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.